The US FDA has cleared Dräger’s Globe-Trotter GT5400 neonatal transport system, a universal transport incubator system that incorporates essential functions such as thermoregulation, ventilation, vibration damping, intravenous infusion pumps, and monitors.
Designed to move effortlessly between helicopters, airplanes and ambulances, GT5400 meets global safety certifications and incorporates high-performance components that are critical for the care of neonatal patients. In the U.S., it is estimated that close to 70,000 neonates are subject to inter- or intra-hospital transport each year.
The GT5400 will be introduced at the annual American Association for Respiratory Care (AARC) Congress, Dec. 9-12, in Las Vegas.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management
- Edition Archive